INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 44 filers reported holding INSMED INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,008,000 | -13.0% | 30,790 | -14.0% | 0.02% | -21.9% |
Q4 2019 | $3,457,000 | +117.0% | 35,790 | +88.4% | 0.03% | +146.2% |
Q3 2019 | $1,593,000 | -91.8% | 19,000 | -90.5% | 0.01% | -90.3% |
Q2 2019 | $19,497,000 | +126.3% | 200,000 | +135.3% | 0.13% | +69.6% |
Q1 2019 | $8,616,000 | +834.5% | 85,000 | +750.0% | 0.08% | +887.5% |
Q2 2018 | $922,000 | -27.7% | 10,000 | -31.0% | 0.01% | -20.0% |
Q1 2018 | $1,275,000 | – | 14,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |